Agiliti, Inc. provides healthcare technology management and service solutions to the healthcare industry in the United States. The company offers onsite managed services, including programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity; and clinical engineering services comprising maintenance, repair, and remediation solutions for various type of medical equipment, including general biomedical and diagnostic imaging equipment through supplemental and outsourced offerings. It also provides equipment solutions, which primarily provide supplemental, peak need, and per-case rental of general biomedical, specialty, and surgical equipment to acute care hospitals and alternate site providers, including premier healthcare institutions and integrated delivery networks. As of December 31, 2020, it owned or managed approximately a million units of medical equipment for approximately 7,000 national, regional, and local acute care hospitals, health system integrated delivery networks, and alternate site providers. Agiliti, Inc. was founded in 2018 and is headquartered in Minneapolis, Minnesota.
IPO Year: 2021
Exchange: NYSE
Website: agilitihealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/7/2024 | $10.00 | Buy → Neutral | UBS |
| 2/6/2024 | Sector Weight | KeyBanc Capital Markets | |
| 1/4/2024 | $23.00 | Buy | Craig Hallum |
| 11/14/2023 | $16.00 → $10.00 | Neutral → Buy | UBS |
| 9/5/2023 | $18.00 → $11.00 | Neutral → Underperform | BofA Securities |
| 8/24/2023 | $15.00 → $10.00 | Equal-Weight → Underweight | Morgan Stanley |
| 8/15/2023 | $20.00 → $13.00 | Buy → Neutral | Citigroup |
| 8/10/2023 | Outperform → Mkt Perform | Raymond James | |
| 1/6/2023 | Overweight → Equal-Weight | Morgan Stanley | |
| 12/16/2022 | $19.00 | Buy → Neutral | BofA Securities |